Effectiveness of tissue-type plasminogen activator for acute ischemic stroke: Consequences of protocol violation

Effectiveness of tissue-type plasminogen activator for acute ischemic stroke: Consequences of protocol violation

Opis bibliograficzny
Główni autorzy:	Karbalai, H, Demchuk, A, Hoyte, K, Klein, G, Feasby, T, Buchan, A
Format:	Journal article
Wydane:	1999

Podobne zapisy

Effectiveness of t-PA in acute ischemic stroke: outcome relates to appropriateness.
od: Buchan, A, i wsp.
Wydane: (2000)

Treatment of the patient with acute ischemic stroke
od: Klein, G, i wsp.
Wydane: (1998)

Stroke thrombolysis: is tissue plasminogen activator a defibrillator for the brain?
od: Buchan, A, i wsp.
Wydane: (2000)

Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke.
od: Demchuk, A, i wsp.
Wydane: (1999)

Does the application of X-ray contrast agents impair the clinical effect of intravenous recombinant tissue-type plasminogen activator in acute ischemic stroke patients?
od: Dzialowski, I, i wsp.
Wydane: (2012)

Cost utility analysis of intravenous tissue plasminogen activator in acute ischemic stroke in Canada
od: Demaerschalk, B, i wsp.
Wydane: (2003)

Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke.
od: Hill, MD, i wsp.
Wydane: (2000)

Tissue plasminogen activator and patients with acute ischemic stroke: The litigation landscape
od: Latha Ganti, i wsp.
Wydane: (2022-02-01)

Complications associated with recombinant tissue plasminogen activator therapy for acute ischaemic stroke.
od: Balami, J, i wsp.
Wydane: (2013)

Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke.
od: Wang, X, i wsp.
Wydane: (2004)

Angioedema Secondary to IV Tissue Plasminogen Activator Administration for Treatment of Acute Ischemic Stroke
od: Benjamin Chaucer, i wsp.
Wydane: (2018-01-01)

The neurotoxicity of tissue plasminogen activator?
od: Kaur, J, i wsp.
Wydane: (2004)

Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey.
od: Tanne, D, i wsp.
Wydane: (2002)

Imaging Evidence for Cerebral Hyperperfusion Syndrome after Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
od: Yi Zhang, i wsp.
Wydane: (2016-01-01)

The first reported case of acute ischemic stroke treated with tissue plasminogen activator at Mansoura University, Egypt
od: Ahmed Farouk Donia, i wsp.
Wydane: (2017-12-01)

Reactions to alteplase in patients with acute thrombotic stroke - Reply
od: Hill, MD, i wsp.
Wydane: (2000)

Biochemistry of ischemic stroke.
od: Barber, P, i wsp.
Wydane: (2003)

Recombinant Tissue Plasminogen Activator (rtPA) Affects Extremity Motor Progress in Acute Ischemic Stroke Patients
od: Dhianty Ramadhani, i wsp.
Wydane: (2024-12-01)

Evaluation of obstacles to receive tissue plasminogen activator in patients with acute ischemic stroke in Imam Khomeini Hospital of Urmia
od: Hamidreza Mehryar, i wsp.
Wydane: (2024-01-01)

The rise and fall of NMDA antagonists for ischemic stroke.
od: Hoyte, L, i wsp.
Wydane: (2004)

Time is brain: Post-marketing experience with alteplase (tPA) for acute ischemic stroke
od: Hill, MD, i wsp.
Wydane: (2000)

The Utility of Automated ASPECTS in Acute Ischemic Stroke for Intravenous Recombinant Tissue Plasminogen Activator (IV-rtPA) Therapy
od: Soichiro Shibata, i wsp.
Wydane: (2022-11-01)

Is glucose a predictor of hemorrhage after rtPA therapy in acute stroke?
od: Demchuk, A, i wsp.
Wydane: (1998)

Cerebral arterial collateral status, but not venous outflow profiles, modifies the effect of intravenous tissue plasminogen activator in acute ischemic stroke
od: Elif Sarionder Gencer, i wsp.
Wydane: (2024-12-01)

Neuroimaging and Intravenous Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke beyond 4.5 Hours: A Systematic Review
od: Muhammad Ramadhan Ghifari, i wsp.
Wydane: (2025-01-01)

Strategies for therapy in acute ischemic stroke.
od: Buchan, A, i wsp.
Wydane: (2007)

Organised stroke care increases the numbers and the speed with which patients with acute ischemic stroke are thrombolysed
od: Kennedy, J, i wsp.
Wydane: (2002)

Reply: Thrombolysis in acute ischaemic stroke.
od: Balami, J, i wsp.
Wydane: (2014)

Synergistic effects of neuroprotective drugs with intravenous recombinant tissue plasminogen activator in acute ischemic stroke: A Bayesian network meta-analysis.
od: Chun Dang, i wsp.
Wydane: (2024-01-01)

Synergistic effects of neuroprotective drugs with intravenous recombinant tissue plasminogen activator in acute ischemic stroke: A Bayesian network meta-analysis
od: Chun Dang, i wsp.
Wydane: (2024-01-01)

Acute ischaemic stroke. Thrombolysis for acute ischaemic stroke works.
od: Hill, MD, i wsp.
Wydane: (2000)

Tissue plasminogen activator does not increase neuronal damage in rat models of global and focal ischemia.
od: Klein, G, i wsp.
Wydane: (1999)

Treating stroke - Response
od: Buchan, A, i wsp.
Wydane: (2000)

Building a "brain attack" team to administer thrombolytic therapy for acute ischemic stroke.
od: Hill, MD, i wsp.
Wydane: (2000)

Is intravenous recombinant tissue plasminogen activator (rt-PA) safe for use in patients over 80 years old with acute ischaemic stroke? - The Calgary experience.
od: Simon, J, i wsp.
Wydane: (2004)

The Impact of Gender on Mortality and Symptomatic Intracerebral Hemorrhage in Acute Ischemic Stroke Patients After Intravenous Recombinant Tissue Plasminogen Activator (rt-PA)
od: Thapanawong Mitsungnern, i wsp.
Wydane: (2023-05-01)

Analysis of predictors of hemorrhagic transformation after reperfusion therapy with recombinant tissue plasminogen activator in patients with acute ischemic stroke: a single-center experience
od: Mahmoud H. Nassar, i wsp.
Wydane: (2024-09-01)

Does application of radio contrast media prior to thrombolysis impact thrombolytic effect in acute ischemic stroke?
od: Dzialowski, I, i wsp.
Wydane: (2008)

An improved scoring system for identifying patients at high early risk of stroke and functional impairment after an acute transient ischemic attack or minor stroke.
od: Coutts, S, i wsp.
Wydane: (2008)

Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study.
od: Hill, MD, i wsp.
Wydane: (2005)